Seeing Is Believing
Currently out of the existing stock ratings of Mohan Naidu, 66 are a BUY (97.06%), 2 are a HOLD (2.94%).
Analyst Mohan Naidu, carries an average stock price target met ratio of 80.99% that have a potential upside of 30.96% achieved within 580 days.
Mohan Naidu’s has documented 149 price targets and ratings displayed on 12 stocks. The coverage was on Healthcare, Technology sectors.
Most recent stock forecast was given on EVH, Evolent Health at 23-Jan-2025.
Analyst best performing recommendations are on TRHC (TABULA RASA HEALTHCARE).
The best stock recommendation documented was for OMCL (OMNICELL) at 10/26/2018. The price target of $73 was fulfilled within 12 days with a profit of $8.5 (13.18%) receiving and performance score of 10.98.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy
$120
$29.48 (32.57%)
$100
5 days ago
(07-Oct-2025)
7/8 (87.5%)
$27.91 (30.31%)
408
Buy
$126
$35.48 (39.20%)
$125
1 months 10 days ago
(02-Sep-2025)
7/10 (70%)
$30.46 (31.88%)
133
Buy
$125
$34.48 (38.09%)
$125
1 months 10 days ago
(02-Sep-2025)
21/25 (84%)
$29.46 (30.84%)
176
Buy
$134
$43.48 (48.03%)
$130
1 months 10 days ago
(02-Sep-2025)
9/11 (81.82%)
$38.46 (40.26%)
396
Buy
$115
$24.48 (27.04%)
$103
4 months 8 days ago
(04-Jun-2025)
17/18 (94.44%)
$2.3 (2.04%)
198
What Year was the first public recommendation made by Mohan Naidu?